UROPLASTY INC 4
4 · UROPLASTY INC · Filed Apr 2, 2015
Insider Transaction Report
Form 4
Reynolds Brett
Senior V.P. CFO
Transactions
- Disposition to Issuer
Common Stock
2015-03-31−138,000→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2015-03-31−100,000→ 0 totalExercise: $2.97Exp: 2020-08-11→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Consists of 33,333 shares subject to restricted stock assumed by Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix") in the merger agreement between issuer and Cogentix and replaced with 24,219 shares of Cogentix stock valued at $4.09 per share, 75,000 shares subject to restricted stock assumed by Cogentix and replaced with 54,495 shares of Cogentix stock valued at $4.56 per share and 29,667 shares disposed of pursuant to the merger agreement in exchange for 21,556 shares of Cogentix common stock on the effective date of the merger.
- [F2]This option, which provided for vesting in three almost equal annual installments beginning on August 12, 2014, was assumed by Cogentix in the merger and replaced with an option to purchase 72,661 shares of Cogentix stock for $4.09 per share.